Inactive Instrument
LungLife AI, Inc. Stock
Stocks
LLAI
USU5500L1045
Biotechnology & Medical Research
| 1 day | -2.35% |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Pagano
CEO | Chief Executive Officer | 42 | - |
David Anderson
DFI | Director of Finance/CFO | 63 | - |
Michael Donovan
CTO | Chief Tech/Sci/R&D Officer | 72 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sara Barrington
BRD | Director/Board Member | 59 | 2021-07-07 |
David Anderson
BRD | Director/Board Member | 63 | 2021-07-07 |
Paul Pagano
BRD | Director/Board Member | 42 | 2020-05-14 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24-10-03 | Free | Chief Financial Officer | 386,703 | 1.5173% | ||
| 24-10-03 | Free | Chief Executive Officer | 769,707 | 3.0201% | ||
| 23-08-13 | Buy | Chief Executive Officer | 12,123 | 0.0476% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.35% | +18.57% | - | - | 1.7M | ||
| -2.43% | +9.18% | +117.28% | +130.59% | 4.8B | ||
| +0.23% | +24.49% | +84.12% | +219.67% | 3.42B | ||
| -2.34% | -4.16% | -28.70% | -41.77% | 2.03B | ||
| -1.19% | -6.31% | +141.86% | -40.91% | 1.88B | ||
| -2.66% | +13.46% | +45.85% | +235.29% | 1.51B | ||
| -2.35% | +16.20% | +158.92% | -49.80% | 943M | ||
| -2.46% | +9.59% | -10.00% | +44.17% | 910M | ||
| +6.50% | -1.73% | +24.13% | - | 506M | ||
| -1.37% | -6.17% | -38.23% | -20.03% | 474M | ||
| Average | -0.94% | +9.91% | +55.03% | +59.65% | 1.83B | |
| Weighted average by Cap. | -1.32% | +12.30% | +76.70% | +97.51% |
Employees
8
















